#novo-nordisk

[ follow ]
#ozempic
US news
fromwww.npr.org
3 months ago

The FDA warns patients about counterfeit Ozempic that may be in circulation

FDA warns of counterfeit Ozempic affecting patient safety.
Report includes details about counterfeit serial numbers.
Novo Nordisk acknowledges multiple counterfeit incidents.
Miscellaneous
fromFuturism
7 months ago

Dr. Oz Will Have a Fascinating Conflict of Interest Running Medicare: Ozempic

Mehmet Oz's potential role in leading Medicare raises concerns due to his past connections with Novo Nordisk, makers of Ozempic.
US news
fromwww.npr.org
3 months ago

The FDA warns patients about counterfeit Ozempic that may be in circulation

FDA warns of counterfeit Ozempic affecting patient safety.
Report includes details about counterfeit serial numbers.
Novo Nordisk acknowledges multiple counterfeit incidents.
Miscellaneous
fromFuturism
7 months ago

Dr. Oz Will Have a Fascinating Conflict of Interest Running Medicare: Ozempic

Mehmet Oz's potential role in leading Medicare raises concerns due to his past connections with Novo Nordisk, makers of Ozempic.
more#ozempic
#stock-market
more#stock-market
#obesity
more#obesity
#fda-regulations
Startup companies
fromFast Company
2 months ago

Novo Nordisk posts strong Q1 as weight-loss revolution claims another victim: WeightWatchers

Novo Nordisk's market outlook improves with FDA's ban on GLP-1 drug copycats.
Despite profit forecasts lowering, investor sentiment towards Novo Nordisk remains optimistic.
Startup companies
fromFast Company
2 months ago

Novo Nordisk posts strong Q1 as weight-loss revolution claims another victim: WeightWatchers

Novo Nordisk's market outlook improves with FDA's ban on GLP-1 drug copycats.
Despite profit forecasts lowering, investor sentiment towards Novo Nordisk remains optimistic.
more#fda-regulations
#eli-lilly
fromFast Company
7 months ago
Medicine

Novo Nordisk stock price takes a tumble after the Wegovy maker's next-generation weight-loss drug underwhelms

fromFast Company
7 months ago
Medicine

Novo Nordisk stock price takes a tumble after the Wegovy maker's next-generation weight-loss drug underwhelms

more#eli-lilly
#market-challenges
fromCbsnews
2 months ago
NYC startup

Novo Nordisk CEO Lars Jorgensen, who led company into weight loss drugs, to step down

Startup companies
fromFast Company
2 months ago

Novo Nordisk announces CEO transition as share price slips

Novo Nordisk's CEO Lars Fruergaard Jorgensen is stepping down amid market challenges despite leading the company through significant growth in the weight-loss drug sector.
fromCbsnews
2 months ago
NYC startup

Novo Nordisk CEO Lars Jorgensen, who led company into weight loss drugs, to step down

more#market-challenges
#wegovy
NYC startup
fromwww.nytimes.com
4 months ago

Weight Loss Drug Will Be Offered for $499 a Month for Some Patients

Novo Nordisk reduces Wegovy's price to $499 for cash-paying patients, but government-insured patients still face high costs.
NYC startup
fromwww.nytimes.com
4 months ago

Weight Loss Drug Will Be Offered for $499 a Month for Some Patients

Novo Nordisk reduces Wegovy's price to $499 for cash-paying patients, but government-insured patients still face high costs.
more#wegovy
European startups
fromTechzine Global
3 months ago

SAP is now the most valuable European public company

SAP has become Europe's most valuable company, surpassing Novo Nordisk due to strong investor confidence and growth in cloud-based services.
[ Load more ]